Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mingshan Niu"'
Autor:
Huihui Zhang, Ninghan Zhang, Rong Wang, Tingting Shao, Yuan Feng, Yao Yao, Qingyun Wu, Shengyun Zhu, Jiang Cao, Huanxin Zhang, Zhenyu Li, Xuejiao Liu, Mingshan Niu, Kailin Xu
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-10 (2019)
Abstract Background Acute myeloid leukemia (AML) is a highly heterogeneous malignancy with various outcomes, and therefore needs better risk stratification tools to help select optimal therapeutic options. Methods In this study, we identify miRNAs th
Externí odkaz:
https://doaj.org/article/e6809d5683fc400e9f4eb39452b07a16
Autor:
Chen Yang, Tingting Shao, Huihui Zhang, Ninghan Zhang, Xiaoying Shi, Xuejiao Liu, Yao Yao, Linyan Xu, Shengyun Zhu, Jiang Cao, Hai Cheng, Zhiling Yan, Zhenyu Li, Mingshan Niu, Kailin Xu
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-11 (2018)
Abstract Background Acute myeloid leukemia (AML) is a highly heterogeneous disease. MicroRNAs function as important biomarkers in the clinical prognosis of AML. Methods This study identified miR-425 as a prognostic factor in AML by screening the TCGA
Externí odkaz:
https://doaj.org/article/ca3c49855a054f88a95fa08a31732863
Autor:
Mingshan Niu, Ninghan Zhang, Rong Wang, Tingting Shao, Yuan Feng, Yangling Shen, Xuejiao Liu, Kai Zhao, Shengyun Zhu, Linyan Xu, Yao Yao, Kailin Xu
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Acute myeloid leukemia (AML) requires refined risk stratification tools to drive decisions concerning effective therapeutic strategies. Here, genome-wide screening was carried out for identifying miRNA molecules capable of predicting treatment outcom
Externí odkaz:
https://doaj.org/article/88d3df8167bc4452b71b122ec6e64ba5
Autor:
Yang Jiao, Yifan Pang, Yifeng Dai, Lingxiu Zhang, Jinlong Shi, Mingshan Niu, Zhiheng Cheng, Sun Wu, Lihua Wang, Lin Fu, Yuan Zhang, Xiaoyan Ke, Dong Ma, Xiufeng Wang, Kailin Xu
Publikováno v:
Cancer Gene Therapy, 25(7-8), 207-213. Nature Publishing Group
The mutational spectrum and prognostic stratification of intermediate-risk acute myeloid leukemia (IR-AML), which accounts for a substantial number of AML, are unclear. In order to explore the prognostic significance of the mutational spectrum in IR-
Autor:
Kunming Qi, Jianlin Qiao, Qing-Yun Wu, Bin Pan, Guangjun Jing, Gang Wang, Hai Cheng, Junnian Zheng, Li Zhenyu, Kailin Xu, Wei Sang, Huizhong Li, Jiang Cao, Ming Shi, Jing Zhao, Mingshan Niu, Lingyu Zeng, Chen Wei
Publikováno v:
American Journal of Hematology. 93:851-858
Chimeric antigen receptor T (CAR-T) cell therapy has shown promising results for relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL). The immune response induced by murine single-chain variable fragment (scFv) of the CAR may limit CAR-T cell
Autor:
Zhenyu Li, Mingshan Niu, Huanxin Zhang, Xuejiao Liu, Tingting Shao, Yuan Feng, Ninghan Zhang, Jiang Cao, Huihui Zhang, Kailin Xu, Yao Yao, Shengyun Zhu, Rong Wang, Qing-Yun Wu
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-10 (2019)
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-10 (2019)
Background Acute myeloid leukemia (AML) is a highly heterogeneous malignancy with various outcomes, and therefore needs better risk stratification tools to help select optimal therapeutic options. Methods In this study, we identify miRNAs that could
Autor:
Xuejiao Liu, Ninghan Zhang, Chen Yang, Tingting Shao, Shengyun Zhu, Zhiling Yan, Hai Cheng, Huihui Zhang, Jiang Cao, Linyan Xu, Mingshan Niu, Yao Yao, Zhenyu Li, Xiaoying Shi, Kailin Xu
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-11 (2018)
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-11 (2018)
Background Acute myeloid leukemia (AML) is a highly heterogeneous disease. MicroRNAs function as important biomarkers in the clinical prognosis of AML. Methods This study identified miR-425 as a prognostic factor in AML by screening the TCGA dataset.